PubMed · 9604336
Cationic beta-cyclodextrin derivative for chiral separations.
Abstract
A novel hepta-substituted beta-cyclodextrin bearing the methoxyethylamine group linked to the upper cyclodextrin rim was successfully used as a chiral selector for enantiomeric separation of non-steroidal anti-inflammatory drugs (NSAIDs) and phenoxypropionic acid herbicides (PPAHs). Separation parameters such as pH and concentration were found to have major influences on enantiomeric resolution of the NSAIDs and PPAHs. Results indicate that heptakis(6-methoxyethylamine-6-deoxy)-beta-cyclodextrin [beta-CD-OMe (VII)] performs exceptionally well for the enantiomeric resolution of NSAIDs: indoprofen and fenoprofen (Rs = 11 and 14, respectively). In addition, baseline enantiomeric separation of a mixture of six pairs of PPAHs was achieved in under 30 min. Compared to other cationic beta-cyclodextrins reported in the literature, the beta-CD-OMe (VII) showed improved selectivity for both classes of the aforementioned anionic racemates.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
J L Haynes, S A Shamsi, F O'Keefe, R Darcey, I M Warner. 1998-04-17. Cationic beta-cyclodextrin derivative for chiral separations.. https://doi.org/10.1016/s0021-9673(97)01212-0. https://pubmed.health/record/pubmed%3A9604336/cationic-beta-cyclodextrin-derivative-for-chiral-separations
Citations retain the original authors and DOI and include this site’s record URL. If this discovery service contributed to your research, you can also cite PubMed Health by Indiciae: BibTeX · RIS.